More than 70 mothers in the Philippines whose children were vaccinated against dengue filed a criminal complaint against government and company officials.
VBI Vaccines is aiming for 2019 approval filings for its hepatitis B vaccine if a head-to-head trial against GSK's entrenched Engerix-B succeeds.
As Philippines lawmakers continue probing the country's now-controversial dengue immunization program, a former president has spoken up to defend it.
Serum Institute of India plans to launch four vaccines in the coming years for pneumococcal, HPV, meningococcal and dengue.
The egg-based production process might have made this season's flu shot only 10% effective.
A Sanofi exec defended its dengue shot in the Philippines on Monday as new reports showed local experts had warned against a broad vaccination push.
Philippines' health secretary plans to ask Sanofi for a Dengvaxia refund and to sue the drugmaker amid worries about the dengue shot's safety.
Preliminary results from a trio of phase 1 studies showed promise for the Zika vaccine Sanofi had previously left behind.
On the heels of a safety warning, the Philippines' FDA ordered Sanofi to pull its Dengvaxia shot from the market.
The Philippines halted its dengue vaccination program after Sanofi flagged serious risks for recipients who'd never been infected with the virus.